Buspirone for PMS: does it work?

Buspirone can ease premenstrual irritability for some women, but the overall evidence for PMS is thin and mixed. It's a non-benzodiazepine anti-anxiety medication that acts on the serotonin 1A receptor, different from the SSRIs that are better studied for PMS and PMDD.

The evidence comes from two trials:

• In the trial that compared buspirone with both nefazodone and placebo, buspirone beat placebo on how much better women rated their own improvement, and it appeared to ease self-rated irritability more than placebo did [1]. Other self-rated symptoms didn't separate as clearly from placebo [1].
• A second trial, comparing buspirone directly with fluoxetine, found both drugs improved PMS symptoms over two months with no meaningful difference between them [3]. That result is encouraging, but the trial had no placebo group, so part of the improvement could come from attention or time rather than the drug itself.

Put together, buspirone has some real evidence behind it for PMS, strongest for irritability, but it's based on small trials rather than the larger, repeated studies that back SSRIs.

Four pieces of research inform what we know about buspirone and PMS. Two trials tested it directly for premenstrual symptoms, one tested it for anxiety more broadly in women, and one reviewed how it behaves in practice.

For the fuller picture of how guidelines weigh PMS treatments, see PMS and PMDD research, summarised.

There's no single approved dose or schedule for buspirone in PMS, because it isn't an approved PMS treatment on its own. What's known comes from how it was used in trials.

• Luteal-phase-only: taken for the one to two weeks before a period, averaging about 21 mg a day in the main placebo-controlled trial [1].
• Full-cycle: taken every day of the cycle, averaging about 27 mg a day after switching from luteal-only dosing in the same trial [1].
• Flat daily dose: 10 mg a day for two months, with no luteal-only phase, in the trial comparing it with fluoxetine [3].

A doctor decides your dose, whether to start luteal-phase-only or every day, and how to adjust from there based on how you respond. If you're already tracking your cycle, a DRSP chart gives your doctor daily numbers instead of a rough sense of how the week felt.

Buspirone doesn't work right away. The clinical review of its use describes a slower, more gradual onset of relief compared with benzodiazepines, trading speed for a lower risk of dependence [4].

In the trial against fluoxetine, researchers checked in at one month and again at two months, and buspirone's effect on PMS symptoms was already measurable at the first check-in and held through the second [3]. In the placebo-controlled trial, women stayed on each dosing pattern, luteal-only, then full-cycle, for two menstrual cycles before switching [1].

A reasonable expectation is to give it at least one full cycle, and ideally two, before deciding whether it's helping. Stopping after a single premenstrual week doesn't tell you much either way.

Buspirone's side effects were mild in the trials that measured them.

• Side effects were mild overall in the main PMS trial, and sexual dysfunction specifically wasn't more common than with placebo [1].
• It didn't cause more sexual side effects than placebo, which matters if an SSRI has caused that for you before [1].
• Compared with a benzodiazepine (diazepam) used for anxiety, buspirone caused less drowsiness, fatigue, weakness and incoordination [2].
• It isn't linked to the dependence pattern seen with benzodiazepines [4].

Common complaints with buspirone generally include dizziness, nausea and headache, though the PMS trials themselves described side effects as mild rather than listing them individually [1].

These trials don't tell us how buspirone behaves in pregnancy, while breastfeeding, or alongside other serotonergic medications, so treat those situations as unstudied rather than confirmed safe. A doctor needs your full medication list before starting it, since combining serotonergic drugs needs medical oversight.

Buspirone also hasn't been studied nearly as well as SSRIs specifically for PMDD, the more severe diagnosis. If you've already tried other treatments without relief, buspirone for PMDD covers how it's used there, usually as an add-on rather than a first option. A PMDD specialist can help if a general doctor isn't familiar with how it's diagnosed or treated.

Buspirone is rarely the only thing a doctor reaches for. Guidelines generally recommend SSRIs first for PMDD. This trial's authors suggest buspirone may be a useful alternative when SSRI side effects, especially sexual ones, are hard to tolerate [1]. For PMS more broadly, PMS treatment: what actually helps covers the full range, from SSRIs taken only in the luteal phase to certain hormonal contraceptives and CBT.

Tracking still matters alongside any medication. Knowing which days are hardest, and whether they ease once your period starts, is part of telling PMS apart from premenstrual syndrome's wider definition and other causes of low mood.

While you and a doctor work out whether buspirone helps, you still need something for the moment itself. Niyora is a PMS and PMDD support app. Its Moon feature lets you write down what happened, see it from another angle, and draft a reply you can hold onto for twenty minutes before you respond.